Stock Screener: Medical , Medical-Biomed-Genetics

The medical or healthcare sector comprises of those stocks which are involved in the production of medical goods.
Medical-Biomed-Genetics belongs to the sector Medical. This industry has a Market Cap of 727.93B. The top rated companies for Medical-Biomed-Genetics industry are: Amgen (AMGN) , Celgene (CELG) , Gilead Sciences (GILD).

Select Sector Select Industry
Click on the column to sort the table.
Company Stock Rating Market Cap PE Ratio 1W 52W
Amgen (AMGN)
4.3/5 121.45B 16.09 -1.64% 10.18%
Biogen Inc (BIIB)
4.3/5 59.44B 16.20 -1.35% 7.63%
Anika Therapeutics (ANIK)
4.2/5 624.65M 19.80 0.97% -6.34%
Cambrex (CBM)
4.2/5 1.72B 20.81 0.98% 15.32%
Gilead Sciences (GILD)
4.1/5 88.23B 6.75 -1.08% -27.22%
China Biologic Products (CBPO)
4.0/5 2.7B 26.50 -0.19% -11.86%
Celgene (CELG)
3.9/5 97.14B 50.17 0.86% 24.24%
Myriad Genetics (MYGN)
3.9/5 1.31B 22.98 -0.57% -48.96%
Regeneron Pharma (REGN)
3.9/5 40.7B 50.34 3.63% 4.13%
PDL BioPharma (PDLI)
3.8/5 339.39M 5.39 2.44% -33.75%
Innoviva (INVA)
3.8/5 1.42B 25.31 2.33% 7.08%
ANI Pharma (ANIP)
3.8/5 562.11M 143.82 7.73% 50.93%
Incyte (INCY)
3.7/5 28.51B 258.30 -1.27% 101.42%
Enzo Biochem (ENZ)
3.7/5 400.89M 12.60 7.11% 96.28%
Illumina (ILMN)
3.7/5 25.21B 54.57 1.8% 8.71%
Alexion Pharma (ALXN)
3.7/5 26.69B 67.73 -1.29% -11.9%
BioTechne Corporation (TECH)
3.6/5 3.77B 47.62 -2.48% 6.4%
Emergent Biosolutions (EBS)
3.6/5 1.18B 30.36 -1.8% -18.81%
AMAG Pharma (AMAG)
3.5/5 760.61M - 2.3% 0.27%
Repligen (RGEN)
3.5/5 1.17B 102.21 2.03% 41.2%
VIVUS (VVUS)
3.5/5 116.14M 4.91 1.89% -10.74%
Integra LifeSciences (IART)
3.4/5 3.22B 46.30 -0.7% 27.34%
Qiagen (QGEN)
3.4/5 6.55B 84.79 0.52% 25.74%
Cytokinetics (CYTK)
3.3/5 529.97M 41.67 -2.34% 83.02%
MiMedx (MDXG)
3.3/5 1.01B 88.18 9.48% 16.03%
Applied Genetic Technologies (AGTC) 3.2/5 123.88M 11.84 0 -51.65
Ligand Pharma (LGND)
3.2/5 2.23B - 1.87% 1.12%
Horizon Pharma (HZNP)
3.2/5 2.41B - -0.76% -9.14%
Heska (HSKA)
3.2/5 692.75M 66.97 -0.79% 223.95%
Osiris Therapeutics (OSIR) 3.1/5 136.09M 78.00 24.47% -10.92%
Vertex Pharma (VRTX)
2.9/5 22.56B - -0.41% 13.16%
Bio-Rad Labs (BIO.B)
2.9/5 5.89B 209.66 1.08% 47.51%
Momenta Pharma (MNTA)
2.8/5 1B - -1.47% 48.13%
Exelixis (EXEL)
2.7/5 6.22B - 3.91% 441.48%
Retrophin (RTRX)
2.7/5 682.65M - 1.15% 37.92%
Acorda Therapeutics (ACOR)
2.6/5 1.23B - 2.15% -0.04%
Alkermes (ALKS)
2.5/5 9.05B - -0.08% 83.5%
Genomic Health (GHDX)
2.5/5 1.09B - 2.39% 28.77%
Vanda Pharmaceuticals (VNDA)
2.5/5 632.84M - 2.15% 83.16%
Array BioPharma (ARRY)
2.4/5 1.59B - -0.85% 219.59%
Sinovac Biotech (SVA)
2.4/5 327.54M - -1.21% -10.5%
Seattle Genetics (SGEN)
2.4/5 9.18B - 2.28% 88.07%
EXACT Sciences (EXAS)
2.4/5 2.54B - 11.52% 257.14%
Galapagos (GLPG)
2.4/5 3.86B 68.81 3.08% 100.07%
NeoGenomics (NEO)
2.3/5 601.42M - -0.78% 17.49%
Amarin (AMRN)
2.3/5 878.76M - 0.94% 115.44%
Halozyme Therapeutics (HALO)
2.3/5 1.85B - 5.34% 59.13%
Organovo (ONVO)
2.3/5 323.67M - 0.66% 39.63%
Kamada (KMDA)
2.3/5 244.2M - -1.45% 81.82%
Arna Pharma (ARNA)
2.3/5 365.75M - 2.1% -21.51%
Cellectis (CLLS)
2.2/5 834.33M - 3.05% -12.13%
Geron (GERN)
2.2/5 361.29M - 5.71% -23.45%
Nymox Pharmaceutical (NYMX) 2.2/5 149.19M - 0.31% 29.55%
Five Prime Therapeutics (FPRX)
2.2/5 1.05B - -2.14% -11.56%
Regenxbio (RGNX)
2.2/5 539.54M - 0.24% 116.7%
Keryx Biopharma (KERX)
2.2/5 643.85M - 8.81% 20.04%
Aduro BioTech (ADRO)
2.1/5 717.38M - 0.47% -14.65%
BioMarin Pharma (BMRN)
2.1/5 15.25B - 1.92% 13.13%
Lexicon Pharma (LXRX)
2.1/5 1.5B - -0.91% 19.49%
Uniquire (QURE)
2.1/5 149.88M - 2.12% -51.39%
Compugen (CGEN)
2.1/5 219.87M - 2.33% -21.29%
Spark Therapeutics (ONCE)
2.0/5 1.65B - -0.09% 55.66%
Inovio Pharma (INO)
2.0/5 463.87M - 8.11% -21.38%
NewLink Genetics (NLNK)
2.0/5 595.71M - 1.98% 18.88%
Coherus Biosciences (CHRS)
2.0/5 1.1B - -7.32% 5.45%
Curis (CRIS)
2.0/5 408.64M - 1.77% 90.73%
Sorrento Therapeutics (SRNE)
2.0/5 208.64M - -3.61% -23.81%
The Medicines Company (MDCO)
1.9/5 3.63B - 2.76% 60.14%
Celldex Therapeutics (CLDX)
1.9/5 414M - 4.94% -8.36%
Intellia Therapeutics (NTLA)
1.9/5 474.78M - 4.3% -38.6%
Kite Pharma (KITE)
1.9/5 4.29B - 2.92% 76.97%
Stemline Therapeutics (STML)
1.9/5 214.21M - -7.26% 84.86%
Merrimack Pharma (MACK)
1.8/5 399.54M - -1.63% -63.11%
Blueprint Medicines (BPMC)
1.8/5 1.46B - 3.09% 149.47%
Evogene (EVGN) 1.8/5 134.29M - 4.05% -17.58%
Acceleron Pharma (XLRN)
1.8/5 1.05B - 0.69% 4.95%
Cellular Biomedicine (CBMG) 1.8/5 162.8M - 3.17% -38.91%
Arbutus Biopharma (ABUS) 1.8/5 178.82M - 3.17% -20.54%
Alnylam Pharma (ALNY)
1.8/5 4.5B - -2.2% -12.97%
Juno Therapeutics (JUNO)
1.8/5 2.21B - 0.58% -44.01%
Idera Pharma (IDRA)
1.8/5 380.19M - 0 27.04
Agenus (AGEN)
1.8/5 395.28M - 1.29% -4.62%
Prothena (PRTA)
1.7/5 1.92B - 6.34% 30.32%
CytomX Therapeutics (CTMX)
1.7/5 662.25M - -7.74% 36.05%
Cara Therapeutics (CARA)
1.7/5 495.55M - 18.65% 214.5%
Editas (EDIT)
1.7/5 842.5M - 4.84% -32.9%
Peregrine Pharma (PPHM)
1.7/5 216.38M - 1.74% 75%
Intercept Pharma (ICPT)
1.7/5 2.91B - -0.4% -6.82%
Achillion Pharma (ACHN)
1.7/5 531.85M - -2.07% -49.87%
Mesoblast (MESO)
1.7/5 694.94M - 8.82% 3.83%
Ophthotech (OPHT) 1.7/5 130.7M - 10.06% -91.73%
Adverum (ADVM) 1.7/5 115.67M - 5.77% -45.87%
bluebird bio (BLUE)
1.7/5 3.84B - 5.68% 128.06%
Acadia Pharma (ACAD)
1.6/5 4.33B - 2.23% 49.98%
Abeona Therapeutics (ABEO)
1.6/5 193.81M - 2.11% 69.58%
ZIOPHARM Oncology (ZIOP)
1.6/5 885.6M - 13.94% -9.81%
Epizyme (EPZM)
1.6/5 1.03B - 4.5% 53.71%
OncoMed Pharma (OMED)
1.5/5 354.91M - -2.12% -7.34%
Immunomedics (IMMU)
1.5/5 737.26M - 8.57% 178.8%
MIRAGEN THERAP (MGEN)
1.5/5 264.33M - 3.15% 63.7%
Merus (MRUS)
1.5/5 401.17M - -2.89% 137.95%
Sangamo BioSciences (SGMO)
1.5/5 297.67M - 1.25% -28.32%
MyoKardia (MYOK)
1.5/5 447.69M - 2.58% 44.19%
Proteostasis (PTI)
1.5/5 285.29M - 2.4% 21.76%
Advaxis (ADXS)
1.5/5 325.18M - 2.34% -9.43%
Revance (RVNC)
1.5/5 592.24M - 3.62% 13.73%
Adaptimmune Therapeutics (ADAP)
1.4/5 323.49M - 6.74% -42.55%
Ascendis Pharma (ASND)
1.4/5 889.96M - -5.86% 52.47%
Dynavax Technologies (DVAX)
1.4/5 268.34M - 3.45% -67.43%
MediciNova (MNOV)
1.4/5 201.99M - 0.86% -15.58%
Novavax (NVAX)
1.4/5 353.53M - 4.03% -75.24%
Vtv Therapeutics (VTVT)
1.4/5 209.38M - 5.28% 17.94%
Sarepta Therapeutics (SRPT)
1.4/5 1.68B - -1.29% 56.1%
Reata Pharma (RETA)
1.4/5 353.61M - -10.77% 76.21%
Syndax Pharma (SNDX)
1.4/5 239.73M - 7.44% 3.63%
NantKwest (NK)
1.4/5 296.27M - 4.96% -57.65%
MannKind (MNKD)
1.3/5 174.31M - -19.31% -81.16%
Wave Life Sciences (WVE) 1.3/5 633.31M - 4.49% 86.67%
Paratek Pharma (PRTK)
1.3/5 420.15M - 12.86% 9.82%
Amicus Therapeutics (FOLD)
1.3/5 1.07B - 4.1% -9.25%
Alder BioPharma (ALDR)
1.3/5 1.08B - 0.72% -14.32%
Insmed (INSM)
1.3/5 1.04B - 10.04% 36.34%
Beigene (BGNE)
1.3/5 1.14B - -4.71% 30.86%
Intra-Cellular Therapies (ITCI)
1.2/5 703.24M - 11.52% -43.65%
Fate Therapeutics (FATE)
1.2/5 199.9M - 4.77% 153.3%
Trevena (TRVN)
1.2/5 212.52M - 12.61% -55.3%
Pharming Group (PHGUF) - 153.57M - 0.31% -4.41%
Power 3 Medical (PWRM) - 0.06M - N/A N/A
Regenerx Biopharma (RGRX) - 32.04M - -3.23% -60%
VG Life Sciences (VGLS) - 1.22M - 20% -60%
CSL Ltd (CMXHY) - 30.75B - N/A N/A
Volitionrx (VNRX) - 109.21M - 1.94% 13.51%
Dendreon (DNDNQ) - 5.4M - N/A N/A
Taxus Cardium Pharma (CRXM) - 2.77M - -7.62% 14.12%
Mymetics (MYMX) - 6.08M - 15.79% 10%
GeneLink (GNLKQ) - 0.19M - 0 0
Neurologix (NRGXQ) - 0.04M - 0 0
Accentia BioPharma (ABPI) - 0.01M - N/A N/A
Starpharma (SPHRY) - 199.35M - 4.4% 10.37%
Oragenics (OGEN) - 22.17M - 6.98% -53.54%
Prodite Pharma (PPMD) - 0.35M - 0 248
Gliatech (GLIAQ) - 0M - N/A N/A
SCOLR Pharma (SCLR) - 0.04M - N/A N/A
Cellcyte Genetics (CCYG) - 0.14M - 0 0
Vitro Diagnostics (VODG) - 1.59M - 21.88% 9.86%
Cormedix (CRMD) - 68.41M - 3.21% -35.6%
Amarillo (AMAR) - 4.92M - -8% 76.92%
Ultragenyx Pharma (RARE) - 2.92B - -13.65% 14.43%
Neuro Hitech (NHPI) - 0M - 0 0
Igene Biotechnology (IGNE) - 0.47M - 0 0
PROTAGENIC THER (PTIX) - 22.57M - 0 -84.19
Tengion (TNGNQ) - 0.08M - 0 0
Bionovo (BNVIQ) - 0.02M - 0 0
Palatin Technologies (PTN) - 45.49M - 1.56% -43.48%
Genitope (GTOPQ) - 0.06M - 0 0
Deltagen (DGEN) - 0M - 0 -100
Unigene Laboratories (UGNEQ) - 0.08M - 0 0
Helix Biomedix (HXBM) - 7.84M - 0 0.43
USA Equities Corp (USAQ) - 0.02M - 0 -96.67
DBV Tech (DBVT) - 1.69B - 0 10.47
Marina Biotech (MRNA) - 21.1M - -4.17% 86.99%
Vital Therapies (VTL) - 126.97M - 5.13% -53.88%
Nanobac Pharma (NNBP) - 0.2M - 0 0
Pfenex (PFNX) - 135.56M 25.48 2.27% -32.41%
IR Biosciences (IRBS) - 0M - 0 -100
Advanced Life Sciences (ADLS) - 0M - 0 -100
BioForce Nanosciences (BFNH) - 0.28M - 0 37.5
BioTime (BTX) - 361.38M 9.68 4.44% 23.22%
Protalix Biotherapeutics (PLX) - 145.24M - 6.9% 42.53%
Rexahn Pharma (RNN) - 121.1M - 17.81% 51.22%
Health Discovery (HDVY) - 2.2M - 0 -74.19
VIA Pharma (VIAP) - 0.08M - 0 33.33
Respirerx Pharma (RSPI) - 7.67M - 1.33% -51.92%
Polymedix (PYMXQ) - 0M - N/A N/A
iBio (IBIO) - 39.2M - 0 -23.64
Savient Pharma (SVNTQ) - 0.59M - N/A N/A
Myrexis (MYRX) - 1.83M - -13.11% -35.37%
Introgen Therapeutics (INGNQ) - 0M - N/A N/A
Akesis Pharma (AKESQ) - 0.03M - N/A N/A
Bellus Health (BLUSF) - 14.04M - 1.52% -82.91%
Oncolytics Biotech (ONCYF) - 55.27M - -6.98% 28.28%
Protein Polymer (PPTIQ) - 0.06M - 0 -100
Wowi (WOWU) - 6.95B - -28.57% 212.5%
Genmab (GNMSF) - 12.15B 108.62 0 56.25
Viralytics (VRACY) - 216.26M - 0 83.67
Cel-Sci Corporation (CVM) - 18.14M - -5.75% -84.84%
Asterias Biotherapeutics (AST) - 163.4M - 12.7% -27.55%
Nicox (NICXF) - 236.3M - 0 23.21
Interleukin Genetics (ILIU) - 27.5M - 31.87% 9.09%
Insite Vision (INSV) - 45.85M - N/A N/A
Synthetic Biologics (SYN) - 81.2M - -4.13% -70.87%
Avax Technologies (AVXT) - 2.41M - 33.33% -71.43%
Immune Therapeutics (IMUN) - 9.33M - -5% -72.86%
Biocurex (BOCX) - 0M - N/A N/A
Panacos Pharma (PANC) - 0.03M - 0 0
Provectus Biopharma (PVCT) - 18.57M - 28.95% -86.86%
Regenicin (RGIN) - 23.02M - -19.38% 460.87%
Guangzhou Pharma (GZPHY) - 726.88M - 0 0
ZYTO Corp (KAEN) - 1.08M - 0 10.71